J.B. Chemicals & Pharmaceuticals Limited (JBCPL), a pharmaceutical company in India, announced that it will acquire brands for the India market from Sanzyme Private Limited (Sanzyme), a leading player in the probiotics and reproductive health segment in the country. The transaction is valued at INR ~ 628 crore and is expected to be completed in…